Trial
NCT03384836
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Phase ISUSPENDEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Stage IIIC Cutaneous Melanoma AJCC v7
Intervention
Laboratory Biomarker Analysis
Why stopped
interim Analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-02